白介素-18细胞因子的生物学作用
摘要
先天和获得性免疫反应。IL-18由造血细胞和非造血细胞产生，包括单核细胞、巨噬细胞、角质形成细胞和间充质细
胞。IL-18可潜在地诱导炎症和细胞毒性免疫细胞活性，导致自身免疫。本文就IL-18在炎症和免疫中的生物学特性
及其诱导、调节和治疗进行综述。
关键词
全文:
PDF参考
[1]Okamura H, Tsutsi H, Komatsu T, et al. Cloning of
a new cytokine that induces IFN-gamma production by T
cells. Nature. 1995. 378(6552): 88-91.
[2]Dinarello CA. IL-18: A TH1-inducing,
proinflammatory cytokine and new member of the IL-1
family. J Allergy Clin Immunol. 1999. 103(1 Pt 1): 11-24.
[3]Ushio S, Namba M, Okura T, et al. Cloning of the
cDNA for human IFN-gamma-inducing factor, expression
in Escherichia coli, and studies on the biologic activities of the
protein. J Immunol. 1996. 156(11): 4274-9.
[4]Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H.
Interleukin-18 regulates both Th1 and Th2 responses. Annu
Rev Immunol. 2001. 19: 423-74.
[5]Novick D, Kim S, Kaplanski G, Dinarello CA.
Interleukin-18, more than a Th1 cytokine. Semin Immunol.
2013. 25(6): 439-48.
[6]O'Neill LA. The interleukin-1 receptor/Toll-like
receptor superfamily: 10 years of progress. Immunol Rev.
2008. 226: 10-8.
[7]Ihim SA, Abubakar SD, Zian Z, et al. Interleukin-
18 cytokine in immunity, inflammation, and autoimmunity:
Biological role in induction, regulation, and treatment. Front
Immunol. 2022. 13: 919973.
[8]Dinarello CA, Novick D, Kim S, Kaplanski G.
Interleukin-18 and IL-18 binding protein. Front Immunol.
2013. 4: 289.
[9]Dixon KO, Kuchroo VK. IL-18: throwing off the
shackles to boost anti-tumor immunity. Cell Res. 2020.
30(10): 831-832.
[10]Kaplanski G. Interleukin-18: Biological properties
and role in disease pathogenesis. Immunol Rev. 2018. 281(1):
138-153.
[11]Sugawara S, Uehara A, Nochi T, et al. Neutrophil
proteinase 3-mediated induction of bioactive IL-18 secretion
by human oral epithelial cells. J Immunol. 2001. 167(11):
6568-75.
[12]Latz E, Xiao TS, Stutz A. Activation and regulation of
the inflammasomes. Nat Rev Immunol. 2013. 13(6): 397-411.
[13]Bossaller L, Chiang PI, Schmidt-Lauber C, et al.
Cutting edge: FAS (CD95) mediates noncanonical IL-1β
and IL-18 maturation via caspase-8 in an RIP3-independent
manner. J Immunol. 2012. 189(12): 5508-12.
[14]Rackov G, Tavakoli Zaniani P, Colomo Del Pino S,
et al. Mitochondrial reactive oxygen is critical for IL-12/IL-18-
induced IFN-γ production by CD4(+) T cells and is regulated
by Fas/FasL signaling. Cell Death Dis. 2022. 13(6): 531.
[15]Zhou T, Damsky W, Weizman OE, et al. IL-
18BP is a secreted immune checkpoint and barrier to IL-18
immunotherapy. Nature. 2020. 583(7817): 609-614.
[16]Sims JE, Smith DE. The IL-1 family: regulators of
immunity. Nat Rev Immunol. 2010. 10(2): 89-102.
[17]Ge Y, Chen J, Qiu X, et al. Natural killer cell
intrinsic toll-like receptor MyD88 signaling contributes
to IL-12-dependent IFN-γ production by mice during
infection with Toxoplasma gondii. Int J Parasitol. 2014. 44(7):
475-84.
[18]Adachi O, Kawai T, Takeda K, et al. Targeteddisruption of the MyD88 gene results in loss of IL-1- and
IL-18-mediated function. Immunity. 1998. 9(1): 143-50.
[19]Bu J, Mahan Y, Zhang S, et al. Acacetin inhibits
inflammation by blocking MAPK/NF-κB pathways and
NLRP3 inflammasome activation. Front Pharmacol. 2024. 15:
1286546.
[20]El-Darawish Y, Li W, Yamanishi K, et al. Frontline
Science: IL-18 primes murine NK cells for proliferation
by promoting protein synthesis, survival, and autophagy. J
Leukoc Biol. 2018. 104(2): 253-264.
[21]Deason K, Troutman TD, Jain A, et al. BCAP
links IL-1R to the PI3K-mTOR pathway and regulates
pathogenic Th17 cell differentiation. J Exp Med. 2018.
215(9): 2413-2428.
[22]Zhou J, Ping FF, Lv WT, Feng JY, Shang J.
Interleukin-18 directly protects cortical neurons by activating
PI3K/AKT/NF-κB/CREB pathways. Cytokine. 2014.
69(1): 29-38.
[23]Fukao T, Tanabe M, Terauchi Y, et al. PI3Kmediated negative feedback regulation of IL-12 production
in DCs. Nat Immunol. 2002. 3(9): 875-81.
[24]Alboni S, Montanari C, Benatti C, et al. Interleukin 18
activates MAPKs and STAT3 but not NF-κB in hippocampal
HT-22 cells. Brain Behav Immun. 2014. 40: 85-94.
[25]傅奕，赵惠仁.白介素18结合蛋白研究进展.生
命科学.2002.（01）：40-42+5.
[26]Nold-Petry CA, Lo CY, Rudloff I, et al. IL-37
requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to
carry out its multifaceted anti-inflammatory program upon
innate signal transduction. Nat Immunol. 2015. 16(4): 354-65.
[27]Detry S, Andries J, Bloch Y, Gabay C, Clancy DM,
Savvides SN. Structural basis of human IL-18 sequestration
by the decoy receptor IL-18 binding protein in inflammation
and tumor immunity. J Biol Chem. 2022. 298(5): 101908.
[28]Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18
in Health and Disease. Int J Mol Sci. 2019. 20(3): 649.
[29]Li X, Cui W, Hull L, Wang L, Yu T, Xiao M.
IL-18 binding protein (IL-18BP) as a novel radiation
countermeasure after radiation exposure in mice. Sci Rep.
2020. 10(1): 18674.
[30]Kim SH, Eisenstein M, Reznikov L, et al. Structural
requirements of six naturally occurring isoforms of the IL-18
binding protein to inhibit IL-18. Proc Natl Acad Sci U S A.
2000. 97(3): 1190-5.
[31]Bao J, Chen Z, Xu L, Wu L, Xiong Y. Rapamycin
protects chondrocytes against IL-18-induced apoptosis and
ameliorates rat osteoarthritis. Aging (Albany NY). 2020. 12(6):
5152-5167.
[32]唐月华，王小平.溃疡性结肠炎患者血清IL-1β
和IL-18的 表 达 及 临 床 意 义.河 北 医 药.2015.37（10）：
1534-1535.
[33]Harel M, Fauteux-Daniel S, Girard-Guyonvarc'h C,
Gabay C. Balance between Interleukin-18 and Interleukin-
18 binding protein in auto-inflammatory diseases. Cytokine.
2022. 150: 155781.
[34]Plater-Zyberk C, Joosten LA, Helsen MM, et al.
Therapeutic effect of neutralizing endogenous IL-18 activity
in the collagen-induced model of arthritis. J Clin Invest.
2001. 108(12): 1825-32.
[35]Li X, Zhang C, Chen W, et al. Protective effect of
neutralizing anti-IL-18α monoclonal antibody on a mouse
model of acute graft-versus-host disease. Oncol Rep. 2015.
34(4): 2031-9.
[36]Jelusic M, Lukic IK, Batinic D. Biological agents
targeting interleukin-18. Drug News Perspect. 2007. 20(8):
485-94.
[37]Sollberger G, Strittmatter GE, Garstkiewicz M,
Sand J, Beer HD. Caspase-1: the inflammasome and beyond.
Innate Immun. 2014. 20(2): 115-25.
[38]Bauer C, Duewell P, Mayer C, et al. Colitis induced
in mice with dextran sulfate sodium (DSS) is mediated by the
NLRP3 inflammasome. Gut. 2010. 59(9): 1192-9.
[39]Tsutsumi N, Yokota A, Kimura T, et al. An innate
interaction between IL-18 and the propeptide that inactivates
its precursor form. Sci Rep. 2019. 9(1): 6160.
[40]Territo PR, Zarrinmayeh H. P2X(7) Receptors in
Neurodegeneration: Potential Therapeutic Applications From
Basic to Clinical Approaches. Front Cell Neurosci. 2021. 15:
617036.
[41]McKie EA, Reid JL, Mistry PC, et al. A Study to
Investigate the Efficacy and Safety of an Anti-Interleukin-18
Monoclonal Antibody in the Treatment of Type 2 Diabetes
Mellitus. PLoS One. 2016. 11(3): e0150018.
[42]Li S, Jiang L, Beckmann K, et al. A novel anti-human
IL-1R7 antibody reduces IL-18-mediated inflammatory
signaling. J Biol Chem. 2021. 296: 100630.
Refbacks
- 当前没有refback。
